WO2005094384A3 - Methods and compositions for treatment of ion imbalances - Google Patents
Methods and compositions for treatment of ion imbalances Download PDFInfo
- Publication number
- WO2005094384A3 WO2005094384A3 PCT/US2005/011010 US2005011010W WO2005094384A3 WO 2005094384 A3 WO2005094384 A3 WO 2005094384A3 US 2005011010 W US2005011010 W US 2005011010W WO 2005094384 A3 WO2005094384 A3 WO 2005094384A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- treatment
- ion imbalances
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/04—Acids; Metal salts or ammonium salts thereof
- C08F120/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F128/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur
- C08F128/02—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur by a bond to sulfur
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2557999A CA2557999C (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
EP05747062A EP1732524B1 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
BRPI0509331A BRPI0509331B8 (en) | 2004-03-30 | 2005-03-30 | use of a sodium binding composition |
DE112005000725.1T DE112005000725B4 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treating ion imbalances |
GB0621244A GB2430368B (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
KR1020067022590A KR101199608B1 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
JP2007506295A JP5000480B2 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion balance abnormalities |
AU2005228696A AU2005228696B2 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/814,749 US8192758B2 (en) | 2004-03-30 | 2004-03-30 | Ion binding compositions |
US10/813,872 US8282960B2 (en) | 2004-03-30 | 2004-03-30 | Ion binding compositions |
US10/813,872 | 2004-03-30 | ||
US10/814,749 | 2004-03-30 | ||
US10/814,527 | 2004-03-30 | ||
US10/814,527 US7854924B2 (en) | 2004-03-30 | 2004-03-30 | Methods and compositions for treatment of ion imbalances |
US10/965,274 | 2004-10-13 | ||
US10/965,274 US7488495B2 (en) | 2004-03-30 | 2004-10-13 | Ion binding polymers and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005094384A2 WO2005094384A2 (en) | 2005-10-13 |
WO2005094384A3 true WO2005094384A3 (en) | 2006-01-26 |
Family
ID=35054544
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/010747 WO2005097072A1 (en) | 2004-03-30 | 2005-03-30 | Ion binding compositions |
PCT/US2005/011010 WO2005094384A2 (en) | 2004-03-30 | 2005-03-30 | Methods and compositions for treatment of ion imbalances |
PCT/US2005/010978 WO2005097081A1 (en) | 2004-03-30 | 2005-03-30 | Ion binding polymers and uses thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/010747 WO2005097072A1 (en) | 2004-03-30 | 2005-03-30 | Ion binding compositions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/010978 WO2005097081A1 (en) | 2004-03-30 | 2005-03-30 | Ion binding polymers and uses thereof |
Country Status (12)
Country | Link |
---|---|
US (14) | US7776319B2 (en) |
EP (3) | EP1732524B1 (en) |
JP (3) | JP4964122B2 (en) |
KR (3) | KR101228233B1 (en) |
AU (3) | AU2005231424B2 (en) |
BR (3) | BRPI0509331B8 (en) |
CA (3) | CA2558029C (en) |
DE (1) | DE112005000730B4 (en) |
GB (3) | GB2430367B (en) |
MX (1) | MXPA06011270A (en) |
PL (1) | PL1732523T3 (en) |
WO (3) | WO2005097072A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
AU2004266050B2 (en) | 2003-08-26 | 2009-06-18 | Takeda Pharmaceutical Company Limited | Pharmaceutical formulation comprising lanthanum compounds |
CA2558029C (en) * | 2004-03-30 | 2013-05-07 | Ilypsa, Inc. | Ion binding polymers and uses thereof |
KR20130086262A (en) * | 2004-03-30 | 2013-07-31 | 리립사, 인크. | Ion binding polymers and uses thereof |
AU2006294455B2 (en) * | 2005-09-30 | 2013-06-20 | Relypsa, Inc. | Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
WO2007038801A2 (en) * | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof |
WO2007041569A1 (en) * | 2005-09-30 | 2007-04-12 | Ilypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
CN100398112C (en) * | 2006-03-24 | 2008-07-02 | 辽宁诺康生物制药有限责任公司 | Medicine for treating hyperphosphatemia and its preparing method |
RS52706B (en) * | 2006-10-06 | 2013-08-30 | Scil Technology Gmbh | Dried reconstituted vesicle formation for pharmaceutical application |
US8779119B2 (en) | 2006-12-26 | 2014-07-15 | Jnc Corporation | Metal salt of crosslinked cellulose derivative |
US20100324280A1 (en) * | 2006-12-26 | 2010-12-23 | Otsuka Pharmaceutical Factory, Inc. | Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same |
MX2009011898A (en) * | 2007-05-04 | 2009-11-18 | Ironwood Pharmaceuticals Inc | Compositions and methods for treating disorders associated with salt or fluid retention. |
US20110123604A1 (en) * | 2007-08-29 | 2011-05-26 | Sorbent Therapeutics, Inc. | Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
JP5294681B2 (en) * | 2008-04-28 | 2013-09-18 | 東京エレクトロン株式会社 | Substrate processing apparatus and substrate transport method |
AU2013204877B2 (en) * | 2008-08-22 | 2015-10-29 | Vifor (International) Ltd. | Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
WO2010022380A2 (en) * | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
US20100104527A1 (en) * | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
US20100111892A1 (en) * | 2008-08-22 | 2010-05-06 | Relypsa, Inc. | Crosslinked polyfluoroacrylic acid and processes for the preparation thereof |
DE112009002063T5 (en) * | 2008-08-22 | 2012-01-12 | Relypsa, Inc. | Crosslinked cation exchange polymers, compositions and use for treating hyperkalemia |
US20120107381A1 (en) * | 2009-05-13 | 2012-05-03 | Relypsa, Inc. | Powder formulations of potassium-binding active agents |
ES2670580T3 (en) | 2010-03-20 | 2018-05-31 | Relypsa, Inc. | Continuous procedure to prepare polyfluoroacrylate particles |
US9314523B2 (en) | 2010-09-21 | 2016-04-19 | Elwha Llc | Ingestible salt grabber |
CN108969535A (en) | 2011-02-11 | 2018-12-11 | Zs制药公司 | For treating the micro porous zirconium silicate of potassemia |
CN108276277A (en) | 2011-06-27 | 2018-07-13 | 瑞立普萨公司 | The fluorination of Polyacrylate and its derivatives |
US9453092B2 (en) | 2011-06-27 | 2016-09-27 | Relypsa, Inc. | Process for converting a polymeric ester to a polymeric acid |
US9943637B2 (en) | 2012-06-11 | 2018-04-17 | ZS Pharma, Inc. | Microporous zirconium silicate and its method of production |
JP2015529640A (en) * | 2012-07-11 | 2015-10-08 | ズィーエス・ファーマ,インコーポレーテッド | Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and an improved calcium-containing composition for the treatment of hyperkalemia |
US20150196585A1 (en) * | 2012-07-19 | 2015-07-16 | Relypsa, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
US9982940B2 (en) | 2012-08-09 | 2018-05-29 | Patheon Austria Gmbh & Co Kg | Process for drying polymeric materials |
JP6475624B2 (en) | 2012-10-08 | 2019-02-27 | レリプサ, インコーポレイテッド | Potassium binding agents for the treatment of hypertension and hyperkalemia |
US10695365B2 (en) | 2012-10-22 | 2020-06-30 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
MX360684B (en) | 2012-10-22 | 2018-11-13 | Zs Pharma Inc | Microporous zirconium silicate for treating hyperkalemia. |
LT3003327T (en) | 2013-06-05 | 2017-12-27 | Tricida Inc. | Proton-binding polymers for oral administration |
WO2015087985A1 (en) * | 2013-12-11 | 2015-06-18 | 株式会社資生堂 | Marker for early diagnosis of kidney failure |
US9675636B2 (en) * | 2014-01-31 | 2017-06-13 | University Of Kansas | Micelle sequestering polymers |
JP6468780B2 (en) * | 2014-09-30 | 2019-02-13 | 積水化成品工業株式会社 | Hollow resin particles and method for producing the same |
EP3229816B1 (en) | 2014-12-10 | 2020-02-05 | Tricida Inc. | Proton-binding polymers for oral administration |
US9592253B1 (en) | 2015-10-14 | 2017-03-14 | ZS Pharma, Inc. | Extended use zirconium silicate compositions and methods of use thereof |
ITUB20159278A1 (en) | 2015-12-23 | 2017-06-23 | Rjw Pharma Llc | PROCEDURE FOR THE SYNTHESIS OF PATIROMER |
BR112018072714A2 (en) | 2016-05-06 | 2019-02-19 | Tricida, Inc. | hcl binding compositions for and method of treating acid-base disorders |
JP2018125951A (en) * | 2017-01-31 | 2018-08-09 | 日本電産株式会社 | Motor and air blowing device with the same |
EP3703706A4 (en) | 2017-11-03 | 2022-04-27 | Tricida Inc. | Compositions for and method of treating acid-base disorders |
JP7365631B2 (en) * | 2019-09-02 | 2023-10-20 | 国立大学法人福井大学 | Core-shell type polymer fine particles having phosphonic acid or phosphonic acid ester structure, particle dispersion, molded body, and method for producing the fine particles |
CN113244339B (en) * | 2021-06-04 | 2021-09-24 | 南京厚生药业有限公司 | Cholestyramine powder for hyperlipidemia and preparation method thereof |
EP4251171A1 (en) * | 2021-11-17 | 2023-10-04 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Pharmaceutical polymer for treating hyperkalemia and preparation method thereof |
WO2024035944A1 (en) * | 2022-08-12 | 2024-02-15 | University Of Kansas | Extraction of critical minerals using polyanions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141927A (en) * | 1990-07-04 | 1992-08-25 | Marcin Krotkiewski | Antihypertensive preparation comprising an alginate and vitamin D |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2340111A (en) * | 1942-07-03 | 1944-01-25 | Gen Electric | Process for removing cations from liquid media |
US2611730A (en) | 1950-09-02 | 1952-09-23 | Simth Kline & French Lab | Medical preparation for reducing the body level of sodium |
US2798053A (en) * | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US3499960A (en) | 1965-01-25 | 1970-03-10 | Merck & Co Inc | Palatable coated particles of an anion exchange resin |
FR2171934B1 (en) * | 1972-02-16 | 1974-09-13 | Rhone Poulenc Sa | |
US3974272A (en) | 1972-09-01 | 1976-08-10 | Merck & Co., Inc. | Palatable cholestyramine coacervate compositions |
US4143130A (en) | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
US4470975A (en) | 1977-10-21 | 1984-09-11 | The Johns Hopkins University | Method and composition for the elimination of water from an animal body |
US4380590A (en) | 1978-09-19 | 1983-04-19 | Rohm And Haas Company | Emulsion copolymer cation exchange resins |
US4191812A (en) * | 1978-09-19 | 1980-03-04 | Rohm And Haas Company | Ion exchange process involving emulsion ion exchange resins |
SE8003805L (en) | 1980-05-21 | 1981-11-22 | Haessle Ab | A PHARMACEUTICAL PREPARATION WITH IMPROVED EMISSION PROPERTY |
US4362711A (en) | 1980-07-11 | 1982-12-07 | Evreka Inc. | Blood cholesterol level reducing agent and method |
DE3031737A1 (en) | 1980-08-22 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING PEARL POLYMERISATS OF UNIFORM PARTICLE SIZE |
DE3149136A1 (en) * | 1981-12-11 | 1983-06-23 | Robert Bosch Gmbh, 7000 Stuttgart | DEVICE FOR REGULATING THE FUEL-AIR RATIO IN INTERNAL COMBUSTION ENGINES |
JPS6090243A (en) | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | Small spherical crosslinked monoallylamine polymer and its preparation |
US5238924A (en) * | 1984-05-03 | 1993-08-24 | Merck & Co., Inc. | Treatment of renal diseases with ace inhibitors |
KR920006865B1 (en) | 1984-05-18 | 1992-08-21 | 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 | Method and apparatus for coating particles or liquid droplets |
US4747881A (en) | 1985-02-05 | 1988-05-31 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US5186937A (en) | 1985-06-07 | 1993-02-16 | A.E.C. Societe De Chimie Organique Et Biologique | Composition for feeding ruminants |
IT1190349B (en) | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | PHARMACEUTICAL COMPOSITIONS WITH SEQUESTRANT ACTIVITY OF BILE ACIDS CONTAINING COLESTYRAMINE AS THE ACTIVE INGREDIENT, AND PROCEDURE TO PREPARE THEM |
JPS63218713A (en) * | 1987-02-17 | 1988-09-12 | Daikin Ind Ltd | Alpha-fluoroacrylic acid polymer and use thereof |
US4837015A (en) * | 1987-03-05 | 1989-06-06 | Carolina Medical Products Company, Inc. | Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels |
US5210079A (en) * | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
FR2634377B1 (en) * | 1988-06-30 | 1991-09-27 | Cortial | NOVEL EXTENDED RELEASE PHARMACEUTICAL FORM BASED ON AN ACTIVE RESIN-PRINCIPLE COMPLEX |
GB8817015D0 (en) | 1988-07-16 | 1988-08-17 | Reckitt & Colmann Prod Ltd | Method of treatment |
GB8829088D0 (en) | 1988-12-13 | 1989-01-25 | Smith Kline French Lab | Compounds |
US5236701A (en) | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
DE3928990A1 (en) | 1989-09-01 | 1991-03-07 | Bayer Ag | METHOD FOR PRODUCING (ALPHA) -FLUOROACRYLIC ACID DERIVATIVES |
US5112993A (en) | 1989-11-14 | 1992-05-12 | E. I. Du Pont De Nemours And Company | Process for the preparation of difluoromaleic anhydride |
US5091175A (en) | 1990-05-14 | 1992-02-25 | Erbamont Inc. | Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane |
IE914179A1 (en) | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
US5162110A (en) * | 1990-12-19 | 1992-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Binding theophylline to ion exchange resins |
US5281631A (en) | 1991-12-20 | 1994-01-25 | Arch Development Corp. | Phosphonic acid based ion exchange resins |
ES2080549T3 (en) * | 1992-03-28 | 1996-02-01 | Hoechst Ag | MEDICINES BASED ON POLYHYDROXYMETHYLENE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND USE. |
AU672824B2 (en) | 1992-08-20 | 1996-10-17 | E.I. Du Pont De Nemours And Company | Crosslinked polymeric ammonium salts |
AU6818894A (en) | 1993-05-20 | 1994-12-20 | Geltex Pharmaceuticals, Inc. | Process for adjusting ion concentration in a patient and compositions therefor |
US5487888A (en) | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
US5607669A (en) | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
US5618530A (en) | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
JPH09506342A (en) | 1993-11-25 | 1997-06-24 | サルテルナテ・ベー・ブイ | Particles that bind monovalent cations, and uses and methods of the particles for trapping and removing sodium and / or potassium ions |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
US5846990A (en) | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
US5824339A (en) | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
JP3885130B2 (en) | 1996-06-11 | 2007-02-21 | 株式会社大塚製薬工場 | Guanidino compound reducing agent and moisture and potassium ion adsorbent |
AU3508097A (en) | 1996-06-26 | 1998-01-14 | Board Of Regents, The University Of Texas System | Hot-melt extrudable pharmaceutical formulation |
JP2001508762A (en) * | 1996-06-27 | 2001-07-03 | ジー.ディー.サール アンド カンパニー | Particles consisting of an amphiphilic copolymer having a cross-linked outer shell region and inner core region, useful for pharmaceutical and other applications |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
US5935599A (en) | 1996-10-28 | 1999-08-10 | The Board Of Trustees Of The University Of Illinois | Polymer-associated liposomes for drug delivery and method of manufacturing the same |
JPH10130154A (en) | 1996-10-29 | 1998-05-19 | Otsuka Pharmaceut Factory Inc | Life prolongation ratio improver for nephritis patient |
HUP0100469A2 (en) | 1997-12-19 | 2001-08-28 | Smithkline Beecham Corporation | Process for manufacturing bite-dispersion tablets |
US6280717B1 (en) * | 1998-07-31 | 2001-08-28 | Nikken Chemicals Co., Ltd. | Cation exchange resin preparation |
US6294163B1 (en) | 1998-10-02 | 2001-09-25 | Geltex Pharmaceuticals, Inc. | Polymers containing guanidinium groups as bile acid sequestrants |
EP1126880A2 (en) | 1998-11-06 | 2001-08-29 | G.D. SEARLE & CO. | Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
CA2355829A1 (en) * | 1999-01-07 | 2000-07-13 | Louise Templeton | Multiparticulate oral dosage forms |
US6558665B1 (en) | 1999-05-18 | 2003-05-06 | Arch Development Corporation | Encapsulating particles with coatings that conform to size and shape of the particles |
US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
US20030027789A1 (en) | 2000-01-14 | 2003-02-06 | Ippei Yamaoka | Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same |
FR2812632B1 (en) | 2000-08-07 | 2003-03-07 | Solvay | PROCESS FOR THE SYNTHESIS OF FLUOROORGANIC COMPOUNDS |
JP2004517066A (en) | 2000-11-20 | 2004-06-10 | ダウ グローバル テクノロジーズ インコーポレイティド | In vivo use of water-absorbable polymers |
WO2002062356A2 (en) | 2001-02-06 | 2002-08-15 | Ash Medical Systems, Inc. | Monovalent-selective cation exchangers as oral sorbent therapy |
US7033639B2 (en) | 2001-05-16 | 2006-04-25 | Rohm And Haas Company | Polyaniline coating composition |
US6881484B2 (en) | 2001-05-30 | 2005-04-19 | Mitsubishi Kagaku Iatron, Inc. | Core-shell particle including signal-generating substance enclosed therein and process for producing the same |
JP2004149525A (en) | 2002-10-09 | 2004-05-27 | Sekisui Chem Co Ltd | Potassium ion adsorbent, method for producing the same, and therapeutic agent for hyperkalemia |
JP5826445B2 (en) * | 2003-02-25 | 2015-12-02 | フィンフィーズ フィンランド オイ | Simulated moving floor system and method |
WO2005065291A2 (en) | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
CA2558029C (en) | 2004-03-30 | 2013-05-07 | Ilypsa, Inc. | Ion binding polymers and uses thereof |
US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7854924B2 (en) * | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US7429394B2 (en) * | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
US7556799B2 (en) * | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
WO2007041569A1 (en) | 2005-09-30 | 2007-04-12 | Ilypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
AU2006294455B2 (en) | 2005-09-30 | 2013-06-20 | Relypsa, Inc. | Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
US20100111892A1 (en) | 2008-08-22 | 2010-05-06 | Relypsa, Inc. | Crosslinked polyfluoroacrylic acid and processes for the preparation thereof |
US20100104527A1 (en) | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
-
2005
- 2005-03-30 CA CA2558029A patent/CA2558029C/en active Active
- 2005-03-30 KR KR1020067022589A patent/KR101228233B1/en active IP Right Grant
- 2005-03-30 PL PL05732849T patent/PL1732523T3/en unknown
- 2005-03-30 CA CA2557848A patent/CA2557848C/en not_active Expired - Fee Related
- 2005-03-30 GB GB0621242A patent/GB2430367B/en active Active
- 2005-03-30 WO PCT/US2005/010747 patent/WO2005097072A1/en active Application Filing
- 2005-03-30 KR KR1020067022533A patent/KR101153035B1/en active IP Right Grant
- 2005-03-30 BR BRPI0509331A patent/BRPI0509331B8/en not_active IP Right Cessation
- 2005-03-30 MX MXPA06011270A patent/MXPA06011270A/en active IP Right Grant
- 2005-03-30 JP JP2007506518A patent/JP4964122B2/en not_active Expired - Fee Related
- 2005-03-30 EP EP05747062A patent/EP1732524B1/en not_active Not-in-force
- 2005-03-30 AU AU2005231424A patent/AU2005231424B2/en active Active
- 2005-03-30 CA CA2557999A patent/CA2557999C/en not_active Expired - Fee Related
- 2005-03-30 EP EP05732849A patent/EP1732523B9/en active Active
- 2005-03-30 JP JP2007506295A patent/JP5000480B2/en not_active Expired - Fee Related
- 2005-03-30 WO PCT/US2005/011010 patent/WO2005094384A2/en active Application Filing
- 2005-03-30 DE DE112005000730.8T patent/DE112005000730B4/en active Active
- 2005-03-30 JP JP2007506580A patent/JP4974882B2/en active Active
- 2005-03-30 AU AU2005231383A patent/AU2005231383B2/en not_active Ceased
- 2005-03-30 AU AU2005228696A patent/AU2005228696B2/en not_active Ceased
- 2005-03-30 GB GB0621241A patent/GB2430624B/en not_active Expired - Fee Related
- 2005-03-30 EP EP05731099A patent/EP1732516B1/en not_active Not-in-force
- 2005-03-30 US US11/095,760 patent/US7776319B2/en not_active Expired - Fee Related
- 2005-03-30 BR BRPI0509365A patent/BRPI0509365B8/en not_active IP Right Cessation
- 2005-03-30 KR KR1020067022590A patent/KR101199608B1/en active IP Right Grant
- 2005-03-30 BR BRPI0509366A patent/BRPI0509366B8/en active IP Right Grant
- 2005-03-30 GB GB0621244A patent/GB2430368B/en not_active Expired - Fee Related
- 2005-03-30 WO PCT/US2005/010978 patent/WO2005097081A1/en active Application Filing
-
2008
- 2008-03-26 US US12/055,765 patent/US8287847B2/en active Active
- 2008-03-26 US US12/055,746 patent/US8282913B2/en active Active
- 2008-03-26 US US12/055,726 patent/US8216560B2/en active Active
- 2008-09-26 US US12/238,844 patent/US8445014B2/en active Active
-
2010
- 2010-08-16 US US12/857,264 patent/US8409561B2/en active Active
-
2011
- 2011-01-27 US US13/015,134 patent/US8475780B2/en not_active Expired - Lifetime
-
2012
- 2012-10-05 US US13/646,104 patent/US20130272990A1/en not_active Abandoned
- 2012-10-09 US US13/647,894 patent/US8889115B2/en not_active Expired - Lifetime
- 2012-10-09 US US13/647,690 patent/US8778324B2/en active Active
-
2014
- 2014-06-04 US US14/295,950 patent/US20140286891A1/en not_active Abandoned
-
2015
- 2015-12-04 US US14/959,574 patent/US20160082039A1/en not_active Abandoned
-
2016
- 2016-07-14 US US15/210,226 patent/US10485821B2/en not_active Expired - Lifetime
-
2019
- 2019-11-25 US US16/693,800 patent/US20200085856A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141927A (en) * | 1990-07-04 | 1992-08-25 | Marcin Krotkiewski | Antihypertensive preparation comprising an alginate and vitamin D |
Non-Patent Citations (1)
Title |
---|
MOUSTAFINE R.I. ET AL: "Characteristics of interpolyelectrolyte complexes for Eudragit E 100 with sodium alginate.", INTERNATIONAL JOURNAL OF PHARMACEUTICS., vol. 294, no. 1-2, 27 April 2005 (2005-04-27), pages 113 - 120, XP004825465 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005094384A3 (en) | Methods and compositions for treatment of ion imbalances | |
WO2005092039A3 (en) | Crosslinked amine polymers | |
WO2006043984A3 (en) | Crosslinked amine polymers | |
EP1745792A4 (en) | Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease | |
NO20050902L (en) | Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies | |
WO2007078516A3 (en) | Medical devices having multiple charged layers | |
WO2009086206A3 (en) | Compositions and methods for joining non-conjoined lumens | |
WO2007002390A3 (en) | Compositions and methods for modulation of smn2 splicing | |
EP1745793A4 (en) | Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease | |
WO2008112325A3 (en) | Treatment of autoimmune disorders | |
WO2007038801A3 (en) | Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof | |
WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
WO2004030631A3 (en) | Anti-cancer and anti-infectious disease compositions and methods for using same | |
EP2184059A3 (en) | Ion binding polymers and uses thereof | |
PL368572A1 (en) | Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections | |
WO2009004094A3 (en) | Compounds and methods for the treatment of renal disease | |
WO2006042277A3 (en) | Extended release compositions of proton pump inhibitors | |
WO2002100899A3 (en) | Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein | |
WO2006116583A3 (en) | Compositions comprising a polymerized benzimidazole and a buffering agent and methods of using same | |
WO2004103291A3 (en) | Extended release compositions of proton pump inhibitor | |
WO2009012400A3 (en) | Orally administered peptides to improve or prevent hepatic fibrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2557999 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005747062 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005228696 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005228696 Country of ref document: AU Date of ref document: 20050330 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/011210 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2005228696 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580010568.0 Country of ref document: CN Ref document number: 2007506295 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1120050007251 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 0621244.3 Country of ref document: GB Ref document number: 0621244 Country of ref document: GB |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067022590 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005747062 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067022590 Country of ref document: KR |
|
RET | De translation (de og part 6b) |
Ref document number: 112005000725 Country of ref document: DE Date of ref document: 20070503 Kind code of ref document: P |
|
ENP | Entry into the national phase |
Ref document number: PI0509331 Country of ref document: BR |